UniProt ID | KCRM_MOUSE | |
---|---|---|
UniProt AC | P07310 | |
Protein Name | Creatine kinase M-type | |
Gene Name | Ckm | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 381 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.. | |
Protein Sequence | MPFGNTHNKFKLNYKPQEEYPDLSKHNNHMAKVLTPDLYNKLRDKETPSGFTLDDVIQTGVDNPGHPFIMTVGCVAGDEESYTVFKDLFDPIIQDRHGGYKPTDKHKTDLNHENLKGGDDLDPNYVLSSRVRTGRSIKGYTLPPHCSRGERRAVEKLSVEALNSLTGEFKGKYYPLKSMTEQEQQQLIDDHFLFDKPVSPLLLASGMARDWPDARGIWHNDNKSFLVWVNEEDHLRVISMEKGGNMKEVFRRFCVGLQKIEEIFKKAGHPFMWNEHLGYVLTCPSNLGTGLRGGVHVKLANLSKHPKFEEILTRLRLQKRGTGGVDTAAVGAVFDISNADRLGSSEVEQVQLVVDGVKLMVEMEKKLEKGQSIDDMIPAQK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MPFGNTHNKFKLN --CCCCCCCCCCCCC | 27.49 | 24899341 | |
9 | Acetylation | PFGNTHNKFKLNYKP CCCCCCCCCCCCCCC | 35.95 | 21728379 | |
9 | Ubiquitination | PFGNTHNKFKLNYKP CCCCCCCCCCCCCCC | 35.95 | - | |
11 | Methylation | GNTHNKFKLNYKPQE CCCCCCCCCCCCCHH | 37.12 | - | |
11 | Acetylation | GNTHNKFKLNYKPQE CCCCCCCCCCCCCHH | 37.12 | 21728379 | |
11 | Ubiquitination | GNTHNKFKLNYKPQE CCCCCCCCCCCCCHH | 37.12 | - | |
14 | Phosphorylation | HNKFKLNYKPQEEYP CCCCCCCCCCHHHCC | 34.19 | 28542873 | |
15 | Acetylation | NKFKLNYKPQEEYPD CCCCCCCCCHHHCCC | 38.87 | 21728379 | |
15 | Ubiquitination | NKFKLNYKPQEEYPD CCCCCCCCCHHHCCC | 38.87 | - | |
20 | Phosphorylation | NYKPQEEYPDLSKHN CCCCHHHCCCHHHCC | 10.99 | 28542873 | |
24 | Phosphorylation | QEEYPDLSKHNNHMA HHHCCCHHHCCCHHH | 38.97 | 23737553 | |
25 | Ubiquitination | EEYPDLSKHNNHMAK HHCCCHHHCCCHHHH | 58.61 | - | |
25 | Acetylation | EEYPDLSKHNNHMAK HHCCCHHHCCCHHHH | 58.61 | 19862969 | |
30 | Sulfoxidation | LSKHNNHMAKVLTPD HHHCCCHHHHHCCHH | 4.14 | 21406390 | |
32 | Acetylation | KHNNHMAKVLTPDLY HCCCHHHHHCCHHHH | 30.15 | 21728379 | |
32 | Ubiquitination | KHNNHMAKVLTPDLY HCCCHHHHHCCHHHH | 30.15 | - | |
35 | Phosphorylation | NHMAKVLTPDLYNKL CHHHHHCCHHHHHHH | 20.11 | 23737553 | |
39 | Phosphorylation | KVLTPDLYNKLRDKE HHCCHHHHHHHCCCC | 20.03 | 28542873 | |
41 | Ubiquitination | LTPDLYNKLRDKETP CCHHHHHHHCCCCCC | 31.20 | - | |
41 | Acetylation | LTPDLYNKLRDKETP CCHHHHHHHCCCCCC | 31.20 | 21728379 | |
100 | Phosphorylation | IQDRHGGYKPTDKHK HCCCCCCCCCCCCCC | 20.56 | 28542873 | |
101 | Acetylation | QDRHGGYKPTDKHKT CCCCCCCCCCCCCCC | 44.72 | 21728379 | |
101 | Ubiquitination | QDRHGGYKPTDKHKT CCCCCCCCCCCCCCC | 44.72 | - | |
103 | Phosphorylation | RHGGYKPTDKHKTDL CCCCCCCCCCCCCCC | 54.23 | 28464351 | |
105 | Ubiquitination | GGYKPTDKHKTDLNH CCCCCCCCCCCCCCC | 49.86 | - | |
107 | Ubiquitination | YKPTDKHKTDLNHEN CCCCCCCCCCCCCCC | 49.85 | - | |
108 | Phosphorylation | KPTDKHKTDLNHENL CCCCCCCCCCCCCCC | 45.50 | 22210690 | |
116 | Acetylation | DLNHENLKGGDDLDP CCCCCCCCCCCCCCH | 72.87 | 21728379 | |
116 | Ubiquitination | DLNHENLKGGDDLDP CCCCCCCCCCCCCCH | 72.87 | - | |
125 | Phosphorylation | GDDLDPNYVLSSRVR CCCCCHHHEEECCCC | 14.25 | 24899341 | |
128 | Phosphorylation | LDPNYVLSSRVRTGR CCHHHEEECCCCCCC | 13.17 | 23737553 | |
129 | Phosphorylation | DPNYVLSSRVRTGRS CHHHEEECCCCCCCC | 30.54 | 24899341 | |
138 | Ubiquitination | VRTGRSIKGYTLPPH CCCCCCCCCCCCCCC | 47.30 | - | |
140 | Phosphorylation | TGRSIKGYTLPPHCS CCCCCCCCCCCCCCC | 10.49 | 28464351 | |
141 | Phosphorylation | GRSIKGYTLPPHCSR CCCCCCCCCCCCCCH | 41.27 | 28542873 | |
146 | S-nitrosylation | GYTLPPHCSRGERRA CCCCCCCCCHHHHHH | 3.51 | 21278135 | |
146 | S-palmitoylation | GYTLPPHCSRGERRA CCCCCCCCCHHHHHH | 3.51 | 26165157 | |
146 | S-nitrosocysteine | GYTLPPHCSRGERRA CCCCCCCCCHHHHHH | 3.51 | - | |
147 | Phosphorylation | YTLPPHCSRGERRAV CCCCCCCCHHHHHHH | 40.04 | 28542873 | |
156 | Ubiquitination | GERRAVEKLSVEALN HHHHHHHHHCHHHHH | 39.19 | - | |
156 | Acetylation | GERRAVEKLSVEALN HHHHHHHHHCHHHHH | 39.19 | 21728379 | |
164 | Phosphorylation | LSVEALNSLTGEFKG HCHHHHHHCCCCCCC | 28.32 | 22817900 | |
166 | Phosphorylation | VEALNSLTGEFKGKY HHHHHHCCCCCCCEE | 34.19 | 19060867 | |
170 | Ubiquitination | NSLTGEFKGKYYPLK HHCCCCCCCEEECCC | 50.63 | - | |
170 | Acetylation | NSLTGEFKGKYYPLK HHCCCCCCCEEECCC | 50.63 | 21728379 | |
172 | Acetylation | LTGEFKGKYYPLKSM CCCCCCCEEECCCCC | 42.05 | 21728379 | |
174 | Phosphorylation | GEFKGKYYPLKSMTE CCCCCEEECCCCCCH | 12.94 | 22817900 | |
178 | Phosphorylation | GKYYPLKSMTEQEQQ CEEECCCCCCHHHHH | 38.32 | 28464351 | |
180 | Phosphorylation | YYPLKSMTEQEQQQL EECCCCCCHHHHHHH | 41.42 | 28464351 | |
196 | Ubiquitination | DDHFLFDKPVSPLLL CCCCCCCCCCHHHHH | 39.73 | - | |
196 | Acetylation | DDHFLFDKPVSPLLL CCCCCCCCCCHHHHH | 39.73 | 21728379 | |
199 | Phosphorylation | FLFDKPVSPLLLASG CCCCCCCHHHHHHHC | 20.54 | 26824392 | |
223 | Ubiquitination | GIWHNDNKSFLVWVN CCEECCCCCEEEEEC | 45.51 | - | |
242 | Acetylation | LRVISMEKGGNMKEV EEEEEEECCCCHHHH | 64.57 | 21728379 | |
242 | Ubiquitination | LRVISMEKGGNMKEV EEEEEEECCCCHHHH | 64.57 | - | |
242 | Succinylation | LRVISMEKGGNMKEV EEEEEEECCCCHHHH | 64.57 | 26388266 | |
247 | Ubiquitination | MEKGGNMKEVFRRFC EECCCCHHHHHHHHH | 55.51 | - | |
254 | S-nitrosocysteine | KEVFRRFCVGLQKIE HHHHHHHHHHHHHHH | 1.94 | - | |
254 | S-nitrosylation | KEVFRRFCVGLQKIE HHHHHHHHHHHHHHH | 1.94 | 21278135 | |
254 | S-palmitoylation | KEVFRRFCVGLQKIE HHHHHHHHHHHHHHH | 1.94 | 26165157 | |
259 | Ubiquitination | RFCVGLQKIEEIFKK HHHHHHHHHHHHHHH | 58.07 | - | |
259 | Acetylation | RFCVGLQKIEEIFKK HHHHHHHHHHHHHHH | 58.07 | 21728379 | |
265 | Ubiquitination | QKIEEIFKKAGHPFM HHHHHHHHHCCCCCC | 47.58 | - | |
265 | Acetylation | QKIEEIFKKAGHPFM HHHHHHHHHCCCCCC | 47.58 | 21728379 | |
266 | Ubiquitination | KIEEIFKKAGHPFMW HHHHHHHHCCCCCCC | 49.18 | - | |
282 | Phosphorylation | EHLGYVLTCPSNLGT CCCCEEEECCCCCCC | 16.60 | - | |
283 | S-nitrosylation | HLGYVLTCPSNLGTG CCCEEEECCCCCCCC | 2.80 | 21278135 | |
283 | S-nitrosocysteine | HLGYVLTCPSNLGTG CCCEEEECCCCCCCC | 2.80 | - | |
285 | Phosphorylation | GYVLTCPSNLGTGLR CEEEECCCCCCCCCC | 47.00 | 28464351 | |
298 | Ubiquitination | LRGGVHVKLANLSKH CCCCEEEEECCCCCC | 27.31 | - | |
298 | Acetylation | LRGGVHVKLANLSKH CCCCEEEEECCCCCC | 27.31 | 21728379 | |
304 | Acetylation | VKLANLSKHPKFEEI EEECCCCCCCCHHHH | 68.07 | 21728379 | |
304 | Ubiquitination | VKLANLSKHPKFEEI EEECCCCCCCCHHHH | 68.07 | - | |
307 | Acetylation | ANLSKHPKFEEILTR CCCCCCCCHHHHHHH | 66.19 | 21728379 | |
307 | Ubiquitination | ANLSKHPKFEEILTR CCCCCCCCHHHHHHH | 66.19 | - | |
313 | Phosphorylation | PKFEEILTRLRLQKR CCHHHHHHHHHHHHC | 33.06 | 28464351 | |
322 | Phosphorylation | LRLQKRGTGGVDTAA HHHHHCCCCCCCHHH | 34.49 | 23737553 | |
327 | Phosphorylation | RGTGGVDTAAVGAVF CCCCCCCHHHHHHEE | 17.70 | 23737553 | |
344 | Phosphorylation | SNADRLGSSEVEQVQ CCCCCCCCCCCEEEE | 28.11 | 28542873 | |
345 | Phosphorylation | NADRLGSSEVEQVQL CCCCCCCCCCEEEEE | 43.81 | 28542873 | |
365 | Acetylation | KLMVEMEKKLEKGQS HHHHHHHHHHHCCCC | 62.44 | 21728379 | |
369 | Ubiquitination | EMEKKLEKGQSIDDM HHHHHHHCCCCHHHC | 73.09 | - | |
372 | Phosphorylation | KKLEKGQSIDDMIPA HHHHCCCCHHHCCCC | 36.33 | 27742792 | |
381 | Ubiquitination | DDMIPAQK------- HHCCCCCC------- | 65.50 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCRM_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCRM_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of KCRM_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...